17-alpha-hydroxyprogesterone has been researched along with Angiogenesis, Pathologic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirakata, A; McInnes, JS; Parikh, I; Proia, AD; Scroggs, MW | 1 |
| Blei, F; Mignatti, P; Rifkin, DB; Wilson, EL | 1 |
| Miyamoto, H; Okada, M; Sato, E; Toyoda, Y | 1 |
| Fujimoto, J; Hori, M; Ichigo, S; Tamaya, T | 1 |
| Stewart, C; Weissman, DE | 1 |
| King, I; Sartorelli, AC; Violette, SM | 1 |
6 other study(ies) available for 17-alpha-hydroxyprogesterone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
The effect of angiostatic steroids and beta-cyclodextrin tetradecasulfate on corneal neovascularization in the rat.
Topics: 17-alpha-Hydroxyprogesterone; Animals; beta-Cyclodextrins; Cornea; Cortodoxone; Cyclodextrins; Dexamethasone; Drug Therapy, Combination; Female; Hydrocortisone; Hydroxyprogesterones; Male; Neovascularization, Pathologic; Nitrates; Potassium Compounds; Rats; Rats, Sprague-Dawley; Silver Nitrate; Steroids | 1993 |
Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
Topics: 17-alpha-Hydroxyprogesterone; Animals; Aorta; Cattle; Cells, Cultured; Dexamethasone; Endothelium, Vascular; Fibroblast Growth Factor 2; Heparin; Hydrocortisone; Hydroxyprogesterones; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Steroids; Urokinase-Type Plasminogen Activator | 1993 |
17 alpha-Hydroxyprogesterone suppresses neovascularization induced by HPLC-purified ovarian hyaluronic acid-like glycosaminoglycan in mice.
Topics: 17-alpha-Hydroxyprogesterone; Animals; Chromatography, High Pressure Liquid; Female; Glycosaminoglycans; Hydroxyprogesterones; Mice; Mice, Inbred ICR; Neovascularization, Pathologic; Ovary | 1995 |
Sex steroids regulate the expression of plasminogen activator inhibitor-1 (PAI-1) and its mRNA in uterine endometrial cancer cell line Ishikawa.
Topics: 17-alpha-Hydroxyprogesterone; Adenocarcinoma; DNA, Neoplasm; Endometrial Neoplasms; Estradiol; Female; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Medroxyprogesterone Acetate; Neoplasm Proteins; Neovascularization, Pathologic; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; Progesterone; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1996 |
Experimental drug therapy of peritumoral brain edema.
Topics: 17-alpha-Hydroxyprogesterone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Edema; Brain Neoplasms; Dexamethasone; Hydrocortisone; Hydroxyprogesterones; Male; Neovascularization, Pathologic; Rabbits | 1988 |
Induction of the terminal differentiation of a human squamous cell carcinoma by steroids with glucocorticoid activity.
Topics: 17-alpha-Hydroxyprogesterone; Androstanols; Carcinoma, Squamous Cell; Cell Differentiation; Desoxycorticosterone; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Hydrocortisone; Hydroxyprogesterones; In Vitro Techniques; Mifepristone; Mineralocorticoids; Neovascularization, Pathologic; Progesterone; Tretinoin; Tumor Cells, Cultured | 1989 |